Matches in Nanopublications for { ?s ?p "[Increased soluble HLA-G (sHLA-G) levels have been reported in patients with melanoma, neuroblastoma, lymphoproliferative disorders, breast, ovarian and colorectal carcinoma when compared to healthy controls or subjects with benign neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP880655.RAAe9PR2UxTP_wloAkhS6VQ-c5GYQh8tAbiiwhIef0hUA130_assertion description "[Increased soluble HLA-G (sHLA-G) levels have been reported in patients with melanoma, neuroblastoma, lymphoproliferative disorders, breast, ovarian and colorectal carcinoma when compared to healthy controls or subjects with benign neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP880655.RAAe9PR2UxTP_wloAkhS6VQ-c5GYQh8tAbiiwhIef0hUA130_provenance.
- NP353758.RA1iAmPZ3SZmCcJK4Jlr7JLQQayeYhfLtKiUF2tgoohYg130_assertion description "[Increased soluble HLA-G (sHLA-G) levels have been reported in patients with melanoma, neuroblastoma, lymphoproliferative disorders, breast, ovarian and colorectal carcinoma when compared to healthy controls or subjects with benign neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP353758.RA1iAmPZ3SZmCcJK4Jlr7JLQQayeYhfLtKiUF2tgoohYg130_provenance.
- NP281769.RAmh7Pu5En6EPoIJz8GlPGTwaQdliDIRd8Exx5v3KJp8A130_assertion description "[Increased soluble HLA-G (sHLA-G) levels have been reported in patients with melanoma, neuroblastoma, lymphoproliferative disorders, breast, ovarian and colorectal carcinoma when compared to healthy controls or subjects with benign neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP281769.RAmh7Pu5En6EPoIJz8GlPGTwaQdliDIRd8Exx5v3KJp8A130_provenance.
- NP910476.RAY7th2aUs0eG4ZRkb4TKi1Y0kVxQHAKx24YDNumftQSQ130_assertion description "[Increased soluble HLA-G (sHLA-G) levels have been reported in patients with melanoma, neuroblastoma, lymphoproliferative disorders, breast, ovarian and colorectal carcinoma when compared to healthy controls or subjects with benign neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP910476.RAY7th2aUs0eG4ZRkb4TKi1Y0kVxQHAKx24YDNumftQSQ130_provenance.
- NP268391.RA7PUaNzWMrM3suDcPzSqPSy_uHElRft9_012RCQhz42Q130_assertion description "[Increased soluble HLA-G (sHLA-G) levels have been reported in patients with melanoma, neuroblastoma, lymphoproliferative disorders, breast, ovarian and colorectal carcinoma when compared to healthy controls or subjects with benign neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP268391.RA7PUaNzWMrM3suDcPzSqPSy_uHElRft9_012RCQhz42Q130_provenance.
- NP753885.RA-dBhJ_IR_t5E4eCiL4CDSv8cR1NhWiAu9iEv5CHtgeM130_assertion description "[Increased soluble HLA-G (sHLA-G) levels have been reported in patients with melanoma, neuroblastoma, lymphoproliferative disorders, breast, ovarian and colorectal carcinoma when compared to healthy controls or subjects with benign neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP753885.RA-dBhJ_IR_t5E4eCiL4CDSv8cR1NhWiAu9iEv5CHtgeM130_provenance.
- NP633841.RAPObBzUqI0R0L9irojKs8eFFZ17leYY9kCf1_zUzG-Zs130_assertion description "[Increased soluble HLA-G (sHLA-G) levels have been reported in patients with melanoma, neuroblastoma, lymphoproliferative disorders, breast, ovarian and colorectal carcinoma when compared to healthy controls or subjects with benign neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP633841.RAPObBzUqI0R0L9irojKs8eFFZ17leYY9kCf1_zUzG-Zs130_provenance.